Status:
COMPLETED
Oral and Anal Swab Sampling in Patients With HPV Positivity
Lead Sponsor:
Medipol University
Collaborating Sponsors:
gaziantep university medicine faculty
Conditions:
HPV
Eligibility:
FEMALE
18-50 years
Brief Summary
Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and G...
Detailed Description
Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient data in the current literature regarding the effectiveness of obtaining oropha...
Eligibility Criteria
Inclusion
- HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3
Exclusion
- HPV-negative women
Key Trial Info
Start Date :
March 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 19 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06906913
Start Date
March 14 2023
End Date
November 19 2024
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziantep Cengiz Gokcek Women's, Obstetrics and Pediatrics Hospital
Gaziantep, Gaziantep, Turkey (Türkiye), 27010